<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Burns Trauma</journal-id><journal-id journal-id-type="iso-abbrev">Burns Trauma</journal-id><journal-title-group><journal-title>Burns &#x00026; Trauma</journal-title></journal-title-group><issn pub-type="ppub">2321-3868</issn><issn pub-type="epub">2321-3876</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31641673</article-id><article-id pub-id-type="pmc">6798408</article-id><article-id pub-id-type="publisher-id">168</article-id><article-id pub-id-type="doi">10.1186/s41038-019-0168-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Surgical outcomes in adults with purpura fulminans: a systematic review and patient-level meta-synthesis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2742-4319</contrib-id><name><surname>Klifto</surname><given-names>Kevin M.</given-names></name><address><phone>1-410-550-0886</phone><email>kklifto@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Gurno</surname><given-names>Caresse F.</given-names></name><address><email>chollen4@jhmi.edu</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Grzelak</surname><given-names>Michael J.</given-names></name><address><email>mgrzela2@jhmi.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Seal</surname><given-names>Stella M.</given-names></name><address><email>sms@jhmi.edu</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Asif</surname><given-names>Mohammed</given-names></name><address><email>masif2@jhmi.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hultman</surname><given-names>C. Scott</given-names></name><address><email>chultma1@jhmi.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Caffrey</surname><given-names>Julie A.</given-names></name><address><email>jcaffre5@jhmi.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution>Department of Plastic and Reconstructive Surgery, </institution><institution>The Johns Hopkins University School of Medicine, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution>The Johns Hopkins University School of Nursing, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution>Welch Medical Library, </institution><institution>The Johns Hopkins University School of Medicine, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff4"><label>4</label>Johns Hopkins Burn Center, 4940 Eastern Avenue, Baltimore, MD 21224 USA </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>7</volume><elocation-id>30</elocation-id><history><date date-type="received"><day>14</day><month>5</month><year>2019</year></date><date date-type="accepted"><day>6</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Cutaneous manifestations of purpura fulminans (PF) present many challenges for clinicians and surgeons. In a state of septic shock complicated by limb ischemia, surgical interventions are necessary to control the pathological cascade and improve patient outcomes. The objective of this article was to report etiologies and surgical outcomes associated with cutaneous manifestations in adults.</p></sec><sec><title>Methods</title><p id="Par2">This systematic review and meta-analysis compared 190 adult patients with etiologies, signs and symptoms, and surgical outcomes associated with cutaneous manifestations of PF. The PubMed, EMBASE, Cochrane Library, Web of Science, and Scopus databases were systematically and independently searched. Patient and clinical characteristics, surgical interventions, outcomes, and complications were recorded.</p></sec><sec><title>Results</title><p>Seventy-nine studies were eligible for the systematic review, and 77 were eligible for meta-analysis using Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) and Cochrane guidelines. A total of 71/190 (38%)&#x000a0;cases reported surgical debridement. Fasciotomies were reported in 12/190 (6%) cases&#x000a0;and 20 procedures. Amputations were reported in 154/190 (81%)&#x000a0;cases. Reconstruction was reported in 45 cases. Skin grafts were applied in 31 cases. Flaps were used for reconstruction in 28 cases. Median (IQR) surgical procedures per patient were 4 (4, 5) procedures. Infectious organisms causing PF were 32% <italic>Neisseria meningitidis</italic> (<italic>n</italic>&#x02009;=&#x02009;55) and 32% <italic>Streptococcus pneumonia</italic> (<italic>n</italic>&#x02009;=&#x02009;55). Coagulase-negative <italic>Staphylococcus</italic> (95%&#x000a0;confidence interval (CI)(8.2&#x02013;177.9), <italic>p</italic>&#x02009;=&#x02009;0.032), <italic>Haemophilus influenza</italic> (95%CI (7.2&#x02013;133), <italic>p</italic>&#x02009;=&#x02009;0.029), <italic>Streptococcus pneumonia</italic> (95% CI (13.3&#x02013;75.9), <italic>p</italic>&#x02009;=&#x02009;0.006), and West Nile Virus (95%CI (8.2&#x02013;177.9), <italic>p</italic>&#x02009;=&#x02009;0.032) were associated with significantly more extensive amputations compared to other organisms.</p></sec><sec><title>Conclusion</title><p id="Par3">This systematic review and patient-level meta-analysis found the most common presentation of PF was septic shock from an infectious organism. <italic>Neisseria meningitidis</italic> and <italic>Streptococcus pneumonia</italic> were equally the most common organisms associated with PF. The majority of cases were not treated in a burn center. The most common surgeries were amputations, with below-the-knee-amputations being the most common procedure. Skin grafting was the most commonly performed reconstructive procedure. The most common complications were secondary infections. Organisms with significantly more extensive amputations were coagulase-negative <italic>Staphylococcus</italic>, <italic>Haemophilus influenza</italic>, <italic>Streptococcus pneumonia</italic>, and West Nile Virus. Interpretation of findings should be cautioned due to limited sample data.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (10.1186/s41038-019-0168-x) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Amputation</kwd><kwd>Burn units</kwd><kwd>Neisseria</kwd><kwd>Purpura fulminans</kwd><kwd>Reconstructive surgical procedures</kwd><kwd>Shock</kwd><kwd>Septic</kwd><kwd>Surgeons</kwd><kwd>Treatment outcome</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par22">Cutaneous manifestations of purpura fulminans (PF) present many challenges for clinicians and surgeons [<xref ref-type="bibr" rid="CR1">1</xref>]. The characteristic pattern of cutaneous purpura results from a pathological combination of disseminated intravascular coagulation (DIC) and endovascular thrombosis [<xref ref-type="bibr" rid="CR2">2</xref>]. Activation of procoagulant and dysfunction of anticoagulant pathways with endothelial damage results in a systemic thrombotic state [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par23">Although first described in 1884 by Guelliot in children suffering from bacterial and viral infections, most children who developed PF have inherited deficiencies in protein C [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. This rare disorder presents in adults most commonly as an acute complication due to an abnormal response to systemic infections [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. <italic>Neisseria meningitis</italic> and <italic>Streptococcus pneumonia</italic> septicemia have been reported as an etiology in as many as 25% of children; however, data for adults is unknown [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. As PF progresses, secondary sequelae from hemorrhagic thrombotic infarcts and coagulopathy contribute to hemodynamic instability and subsequent limb ischemia, limb loss, morbidity, and mortality. In a state of septic shock complicated by limb ischemia, surgical interventions are necessary to control the pathological cascade and improve patient outcomes [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p><p id="Par24">This review provides healthcare providers with insight on outcomes and complications in adults presenting with PF. Patients and families can be informed early of realistic expectations and the need for surgical management when consenting to procedures.</p><p id="Par25">We also report etiologies and surgical outcomes associated with cutaneous manifestations in adults. This article is an attempt to organize the literature to create a uniform set of data for clinical interpretation and management to optimize outcomes and minimize complications.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Materials and methods</title><p id="Par26">Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines were followed throughout the literature search process to structure the framework for the review [<xref ref-type="bibr" rid="CR9">9</xref>]. The structure for our systematic review is a similar format to prior reviews by members of our team.</p><sec id="Sec4"><title>Selection criteria</title><p id="Par27">The participants, interventions, comparisons, outcomes, and study design (PICOS) strategy was followed for inclusion throughout the selection process. Participants were age &#x02265;&#x02009;15&#x02009;years for each study, treated as either inpatients or outpatients, diagnosed with PF (tissue biopsy or case reported), and had a surgical intervention. Interventions were surgical defined as debridement, amputation, or reconstruction (acellular dermal matrix (ADM), allografts, autografts, split-thickness graft, full-thickness graft, skin substitute, cutaneous flap, fascial flap, muscle flap, osseous flap, omental flap) and non-surgical (negative pressure wound therapy, hyperbaric oxygen) intended for direct management of PF. Comparisons were made between the different organisms or etiologies contributing to PF. Outcomes measured were PF etiologies, infectious organisms, burn center management, number of limbs involved, areas of necrosis, percent of total body surface area (%TBSA)&#x000a0;involved, debridement (surgical excision), time to debridement in days, amputation, number of bones removed or transected at amputation, time to amputation in days, flaps, type of flap, time to flap in days, flap survival, skin graft, time to skin graft in days, type of skin graft, skin graft location, skin graft survival, protein C (drotrecogin alfa), intravenous immunoglobulin, antithrombin, plasmapheresis, negative pressure wound therapy, hyperbaric oxygen therapy, hospital length of stay (LOS) in days, total surgical procedures, significant improvement in PF reported following surgery, long-term patient follow-up in days, mortality, and time to mortality in days. Complications measured were scarring, wound contracture, thrombosis, progression of disease, wound infections or abscess, systemic infections, pressure ulcers, fistulas, and non-healing wounds. All outcomes and complications were reported as measured by studies. Study designs considered were randomized controlled trials (RCTs), clustered RCTs, non-randomized controlled trials, retrospective studies, observational studies, prospective studies, case-control studies, cohort studies, case series, and case reports. No predetermined length of follow-up for participants or specific years was considered for publication status. Studies were excluded if they were not in English, were reviews with no contribution of new data, non-peer reviewed literature, cadaver studies, animal studies, full-article were unavailable, patient death occurred prior to surgical management, studies not related to outcomes or complications discussed, and surgical interventions not performed for cutaneous manifestations of PF.</p></sec><sec id="Sec5"><title>Search</title><p id="Par28">A medical library informationist (SMS) conducted the initial literature search using five databases (MEDLINE via PubMed, EMBASE, Cochrane Library, Web of Science, and Scopus) from inception to April 4, 2019 (see Additional&#x000a0;file&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>). Reference lists of relevant articles were hand-searched to identify additional relevant studies. All references were imported into Covidence (Veritas Health Innovation Ltd., Melbourne, Australia) and reference management software. Duplicates were removed.</p></sec><sec id="Sec6"><title>Data extraction</title><p id="Par29">Two reviewers (KMK and CFG) systematically and independently performed the title/abstract screening, followed by a full-text review to ensure quality and accuracy throughout the process. Any disagreements regarding studies included or excluded were resolved by discussion. If disagreements were still present after discussion, a third reviewer (JAC) resolved remaining conflict. The following data were extracted qualitatively and quantitatively for outcome and complication variables of interest: authors, year of publication, type of study, sample size, male and female distributions, age, PF etiologies, infectious organisms, burn center management, number of limbs involved, areas of necrosis, %TBSA, debridement, time to debridement, amputation, time to amputation, flaps, type of flap, flap survival, skin graft, time to skin graft, type of skin graft, skin graft location, skin graft survival, protein C, intravenous immunoglobulin, antithrombin, plasmapheresis, negative pressure wound therapy, hyperbaric oxygen therapy, hospital LOS, total surgical procedures, significant improvement in PF reported following surgery, long-term patient follow-up, mortality and time to mortality. Complications measured were scarring, wound contracture, thrombosis, progression of disease, wound infections or abscess, systemic infections, pressure ulcers, fistulas, and non-healing wounds. If there were multiple reports from the same study, one data collection form was completed for the study from all of the reports to avoid duplicating results.</p></sec><sec id="Sec7"><title>Quality assessment and unit of analysis issues</title><p id="Par30">Two reviewers (KMK and CFG) assessed the risk of bias and study quality individually for each study at a patient data level. Study quality was assessed using the methodological quality and synthesis of case series and case reports [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par31">Amputations were qualified as reported by each individual patient and quantified by the total surgical removal or transection bones of fingers and toes (1st digit&#x02009;=&#x02009;2, 2nd&#x02013;5th digits&#x02009;=&#x02009;3), below-the-knee amputation&#x000a0;(BKA&#x02009;=&#x02009;28), above-the-knee amputation&#x000a0;(AKA&#x02009;=&#x02009;30), distal forearm (<italic>n</italic>&#x02009;=&#x02009;29), and transhumoral (<italic>n</italic>&#x02009;=&#x02009;30). Case reports that reported transtibial amputations, BKAs, and distal lower extremity amputations were all considered BKA. This was applied to other anatomical locations of the body. Total surgical procedures performed were tabulated only if the case report explicitly quantified the number of procedures. Time to debridement, time to amputation, time to the skin graft, hospital LOS, long-term patient follow-up, and time to mortality were converted to days if intervals were reported in hours, weeks, months, or years.</p></sec><sec id="Sec8"><title>Data synthesis and statistical analysis</title><p id="Par32">Descriptive statistics were applied to quantify male and female distributions, age, PF etiologies, infectious organisms, burn center management, number of limbs involved, areas of necrosis, %TBSA, debridement, time to debridement, amputation, time to amputation, flaps, type of flap, flap survival, skin graft, time to skin graft, type of skin graft, skin graft location, skin graft survival, protein C, intravenous immunoglobulin, antithrombin, plasmapheresis, negative pressure wound therapy, hyperbaric oxygen therapy, hospital LOS, total surgical procedures, significant improvement in PF reported following surgery, long-term patient follow-up, mortality, time to mortality, scarring, wound contracture, thrombosis, progression of disease, wound infections or abscess, systemic infections, pressure ulcers, fistulas, and non-healing wounds. We reported medians, interquartile ranges&#x000a0;(IQR), and ranges for non-parametrically distributed data and means and standard deviations for parametrically distributed data. Meta-analysis was performed using individual patient data [<xref ref-type="bibr" rid="CR11">11</xref>]. Outcomes associated with the different organisms were compared using logistic regression and Fisher&#x02019;s exact test for dichotomous variables (amputation, complications, mortality) or linear regression and Mann-Whitney <italic>U</italic> test for continuous variables (bones removed or transected at amputation, time to amputation, hospital LOS) for a non-parametric distribution of data. All meta-analysis outcomes were two-tailed, with a significance level set at <italic>&#x003b1;</italic> of 0.05. Dichotomous and continuous outcomes were reported with 95% confidence intervals (CIs), <italic>p</italic> values, odds ratios (OR), and unstandardized beta coefficients. All meta-analyses were performed with IBM SPSS Version 25.0 (IBM Corporation, Redmond, Washington). No additional analyses were performed during our study.</p></sec></sec></sec><sec id="Sec9"><title>Results</title><sec id="Sec10"><title>Study selection and characteristics</title><p id="Par33">The search resulted in 735 citations; after removing 141 duplicates, 594 citations remained. Following title/abstract review, 154 articles were eligible for full-text review. Manual review of references yielded two additional articles (<italic>n</italic>&#x02009;=&#x02009;156). Following the full-text review, 79 articles were eligible for final data extraction and included in the systematic review (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).
<fig id="Fig1"><label>Fig. 1</label><caption><p>Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) flow chart summarizes the results of the screening process and final article selections</p></caption><graphic xlink:href="41038_2019_168_Fig1_HTML" id="MO1"/></fig></p><p id="Par34">The 79 studies included in the systematic review were published from 1968 through 2019 (see Additional&#x000a0;file&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>: Table S1 and Additional&#x000a0;file&#x000a0;<xref rid="MOESM3" ref-type="media">3</xref>: Table S2) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR87">87</xref>]. The numbers of studies published per decade were one, 1960 to 1969; zero, 1970 to 1979; two, 1980 to 1989; six, 1990 to 1999; 23, 2000 to 2009; and 47, 2010 to 2019 (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). A total of 190 patients age &#x02265;&#x02009;15&#x02009;years were diagnosed with PF and underwent a surgical procedure. There were 68 case studies [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR31">31</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR47">47</xref>&#x02013;<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR65">65</xref>&#x02013;<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR77">77</xref>&#x02013;<xref ref-type="bibr" rid="CR87">87</xref>], nine case series [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR76">76</xref>], one prospective cohort [<xref ref-type="bibr" rid="CR62">62</xref>], and one retrospective cohort [<xref ref-type="bibr" rid="CR28">28</xref>] studies published in English. All outcomes queried were identifiable during data extraction.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Number of purpura fulminans studies published per decade from 1968 to 2019</p></caption><graphic xlink:href="41038_2019_168_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec11"><title>Results and risk of bias of individual studies</title><p id="Par35">Additional&#x000a0;file&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>: Table S1 and Additional&#x000a0;file&#x000a0;<xref rid="MOESM3" ref-type="media">3</xref>: Table S2 summarize the years, sample size, study design, age, sex, etiology, organism, necrosis, debridement, time to debridement, amputation, time to amputation, reconstruction, time to reconstruction, reconstruction location, hospital LOS, complications, mortality, and time to mortality, assessed by each individual study from the 79 articles included in our study. The quality of case-report and case-series studies included in the meta-analysis was provided for each study (see Additional&#x000a0;file&#x000a0;<xref rid="MOESM4" ref-type="media">4</xref>: Table S3).</p></sec><sec id="Sec12"><title>Synthesis of results across studies</title><p id="Par36">Of the 79 studies included in the systematic review, 77 were included in the meta-analysis [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR12">12</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR63">63</xref>&#x02013;<xref ref-type="bibr" rid="CR87">87</xref>]. Two studies were excluded due to inaccessibility of patient-level data to perform the quantitative synthesis. Of the outcomes queried, organism, amputations, time to amputation, burn center management, protein C, hospital LOS, complications, and mortality were evaluated by meta-analysis. Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref> summarize findings from qualitative and quantitative synthesis.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of findings for patient demographics from qualitative and quantitative synthesis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Total number of patients</th><th>Sex</th><th>Age, years<break/>Median (IQR)</th><th>Etiology</th><th>Infectious organism</th></tr></thead><tbody><tr><td>190</td><td><p>&#x02022; Males&#x02009;=&#x02009;94</p><p>&#x02022; Females&#x02009;=&#x02009;89</p><p>&#x02022; Unidentified&#x02009;=&#x02009;7</p></td><td>40 (26&#x02013;58)</td><td><p>&#x02022; Infectious organism&#x02009;=&#x02009;171</p><p>&#x02022; Unknown&#x02009;=&#x02009;9</p><p>&#x02022; Not infectious&#x02009;=&#x02009;6</p><p>&#x02022; No organism found&#x02009;=&#x02009;4</p></td><td><p>&#x02022; <italic>Neisseria meningitidis</italic>&#x02009;=&#x02009;55</p><p>&#x02022; <italic>Streptococccus pneumonia</italic>&#x02009;=&#x02009;55</p><p>&#x02022; <italic>Capnocytophaga canimorsus</italic>&#x02009;=&#x02009;9</p><p>&#x02022; <italic>Escherichia coli</italic>&#x02009;=&#x02009;7</p><p>&#x02022; <italic>Staphylococcus aureus</italic>&#x02009;=&#x02009;6</p><p>&#x02022; <italic>Streptococccus pyogenes</italic>&#x02009;=&#x02009;3</p><p>&#x02022; <italic>Klebsiella pneumonia</italic>&#x02009;=&#x02009;2</p><p>&#x02022; <italic>Haemophilus influenza</italic>&#x02009;=&#x02009;2</p><p>&#x02022; <italic>Plasmodium falciparum</italic>&#x02009;=&#x02009;2</p><p>&#x02022; <italic>Pseudomonas aeruginosa</italic>&#x02009;=&#x02009;1</p><p>&#x02022; <italic>Bacteroides fragilis</italic>&#x02009;=&#x02009;1</p><p>&#x02022; <italic>Capnocytophaga ochracea</italic>&#x02009;=&#x02009;1</p><p>&#x02022; <italic>Pasteurella multocida</italic>&#x02009;=&#x02009;1</p><p>&#x02022; <italic>Chlamydia pneumonia</italic>&#x02009;=&#x02009;1</p><p>&#x02022; <italic>Proteus mirabilis</italic>&#x02009;=&#x02009;1</p><p>&#x02022; <italic>Gemella bergeri</italic>&#x02009;=&#x02009;1</p><p>&#x02022; <italic>Vibrio vulnificus</italic>&#x02009;=&#x02009;1</p><p>&#x02022; Leptospirosis&#x02009;=&#x02009;1</p><p>&#x02022; <italic>Trichosporon asahii</italic>&#x02009;=&#x02009;1</p><p>&#x02022; Cytomegalovirus&#x02009;=&#x02009;1</p><p>&#x02022; Varicella&#x02009;=&#x02009;1</p><p>&#x02022; West Nile Virus&#x02009;=&#x02009;1</p></td></tr></tbody></table><table-wrap-foot><p><italic>IQR</italic> interquartile range</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of findings for patient outcomes from qualitative and quantitative synthesis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Total number of patients</th><th>Debridement</th><th>Time to debridement, days<break/>Median (IQR)</th><th>Amputations<break/>Median (IQR)</th><th>Amputations (bones removed/transected)<break/>Median (IQR)</th><th>Time to amputation, days<break/>Median (IQR)</th><th>Reconstruction (grafts)</th><th>Reconstruction (flaps)</th><th>Time to reconstruction, days<break/>Median (IQR)</th><th>Hospital LOS, days<break/>Median (IQR)</th><th>Complications</th><th>Mortality</th><th>Time to mortality, days<break/>Median (IQR)</th></tr></thead><tbody><tr><td>190</td><td>71/190 cases</td><td>12.5 (1.8&#x02013;20.3)</td><td><p>&#x02022;154/190 cases</p><p>&#x02022;Limbs involved&#x02009;=&#x02009;4 (4&#x02013;4)</p><p>&#x02022;BKA&#x02009;=&#x02009;64</p><p>&#x02022;AKA&#x02009;=&#x02009;30</p><p>&#x02022;Below-the-elbow&#x02009;=&#x02009;28</p><p>&#x02022;Above-the-elbow&#x02009;=&#x02009;3</p></td><td>56 (9&#x02013;84)</td><td>18 (14&#x02013;28)</td><td><p>&#x02022;Total grafts&#x02009;=&#x02009;33</p><p>&#x02022;ADM&#x02009;=&#x02009;3</p><p>&#x02022;STSG&#x02009;=&#x02009;13</p><p>&#x02022;FTSG&#x02009;=&#x02009;1</p><p>&#x02022;Undifferentiated allografts&#x02009;=&#x02009;5</p><p>&#x02022;Undifferentiated autografts&#x02009;=&#x02009;7</p><p>&#x02022;Unknown&#x02009;=&#x02009;4</p></td><td><p>&#x02022;Total flaps&#x02009;=&#x02009;28</p><p>&#x02022;Latissimus dorsi&#x02009;=&#x02009;7</p><p>&#x02022;Orbicularis oris&#x02009;=&#x02009;4</p><p>&#x02022;Serratus anterior&#x02009;=&#x02009;2</p><p>&#x02022;Posterolateral thigh&#x02009;=&#x02009;1</p><p>&#x02022;Free ALT&#x02009;=&#x02009;1</p><p>&#x02022;Free medial gastrocnemius&#x02009;=&#x02009;1</p><p>&#x02022;Gracilis&#x02009;=&#x02009;1</p><p>&#x02022;Internal island saphenous&#x02009;=&#x02009;1</p><p>&#x02022;Free forearm&#x02009;=&#x02009;1</p><p>&#x02022;Lateral arm&#x02009;=&#x02009;1</p><p>&#x02022;Forehead&#x02009;=&#x02009;1</p></td><td>39 (23&#x02013;56)</td><td>57 (43.3&#x02013;87.8)</td><td><p>&#x02022;28/190 cases</p><p>&#x02022;Secondary infection&#x02009;=&#x02009;20</p><p>&#x02022;DVT/PE&#x02009;=&#x02009;5</p><p>&#x02022;Scarring&#x02009;=&#x02009;5</p><p>&#x02022;Wound contracture&#x02009;=&#x02009;3</p><p>&#x02022;Pressure ulcer&#x02009;=&#x02009;1</p><p>&#x02022;Wound breakdown&#x02009;=&#x02009;1</p><p>&#x02022;Alar stenosis&#x02009;=&#x02009;1</p><p>&#x02022;Facial deformity&#x02009;=&#x02009;1</p><p>&#x02022;Heterotopic ossification&#x02009;=&#x02009;1</p></td><td>34/190 cases</td><td>36 (26.3&#x02013;72.8)</td></tr></tbody></table><table-wrap-foot><p><italic>IQR</italic> interquartile range, <italic>BKA</italic> below-the-knee&#x000a0;amputation, <italic>AKA</italic> above-the-knee&#x000a0;amputation, <italic>ADM</italic> acellular dermal matrix, <italic>STSG</italic> split-thickness skin graft, <italic>FTSG</italic> full-thickness skin graft, <italic>ALT</italic> anterolateral thigh, <italic>LOS</italic> length of stay, <italic>DVT</italic> deep vein thrombosis, <italic>PE</italic> pulmonary embolism</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec13"><title>Demographic</title><p id="Par37">A total of 190 cases were identified through qualitative synthesis. Of these, 183 cases included 94 males and 89 females. Of the 190 cases included in the qualitative synthesis, 118 cases were included in the quantitative synthesis from 77 studies. Median (IQR) age was 40&#x02009;years (26&#x02013;58), ranging from 15 to 79&#x02009;years. Median (IQR) limbs involved were four (4-4) limbs, and median (IQR) %TBSA was 45% (26&#x02013;54%), ranging from 20&#x02013;70%. Patients were treated in a burn center in 14/190 (7%) cases&#x000a0;and eight studies.</p></sec><sec id="Sec14"><title>Etiology</title><p id="Par38">The most common etiology reported for qualitative synthesis was an infectious organism (<italic>n</italic>&#x02009;=&#x02009;171), followed by no organisms or unknown statuses of organisms reported in 19 patients. Infectious organisms causing PF were 32% <italic>Neisseria meningitidis</italic> (<italic>n</italic>&#x02009;=&#x02009;55/171), 32% <italic>Streptococcus pneumonia</italic> (<italic>n</italic>&#x02009;=&#x02009;55/171), 9% other organisms (<italic>n</italic>&#x02009;=&#x02009;16/171), 5% <italic>Capnocytophaga canimorsus</italic> (<italic>n</italic>&#x02009;=&#x02009;9/171), 4% <italic>Escherichia coli</italic> (<italic>n</italic>&#x02009;=&#x02009;7/171), 4% <italic>Staphylococcus aureus</italic> (<italic>n</italic>&#x02009;=&#x02009;6/171), <italic>Streptococcus pyogenes</italic> (<italic>n</italic>&#x02009;=&#x02009;3), <italic>Klebsiella pneumonia</italic> (<italic>n</italic>&#x02009;=&#x02009;2), <italic>Haemophilus influenza</italic> (<italic>n</italic>&#x02009;=&#x02009;2), <italic>Plasmodium falciparum</italic> (<italic>n</italic>&#x02009;=&#x02009;2), <italic>Pseudomonas aeruginosa</italic> (<italic>n</italic>&#x02009;=&#x02009;1), <italic>Bacteroides fragilis</italic> (<italic>n</italic>&#x02009;=&#x02009;1), <italic>Capnocytophaga ochracea</italic> (<italic>n</italic>&#x02009;=&#x02009;1), <italic>Pasteurella multocida</italic> (<italic>n</italic>&#x02009;=&#x02009;1), <italic>Chlamydia pneumonia</italic> (<italic>n</italic>&#x02009;=&#x02009;1), <italic>Proteus mirabilis</italic> (<italic>n</italic>&#x02009;=&#x02009;1), <italic>Gemella bergeri</italic> (<italic>n</italic>&#x02009;=&#x02009;1), <italic>Vibrio vulnificus</italic> (<italic>n</italic>&#x02009;=&#x02009;1), Leptospirosis (<italic>n</italic>&#x02009;=&#x02009;1), <italic>Trichosporon asahii</italic> (<italic>n</italic>&#x02009;=&#x02009;1), Cytomegalovirus (<italic>n</italic>&#x02009;=&#x02009;1), Varicella (<italic>n</italic>&#x02009;=&#x02009;1), and West Nile Virus (<italic>n</italic>&#x02009;=&#x02009;1). No organisms or unknown statuses of organisms were reported in 19 patients. Identifiable non-infectious causes included macrophage activating syndrome, small cell lung cancer, breast necrosis, medication-induced fluoroquinolones, and postpartum. The most common etiology included in quantitative synthesis was an infectious organism (<italic>n</italic>&#x02009;=&#x02009;99/118). The most common patient presentation was septic shock. Septic shock was reported from an infectious organism in 84/99 cases.</p></sec><sec id="Sec15"><title>Burn center management</title><p id="Par39">Eight studies (14/190 cases) reported patient transfer to a burn center for higher level care. Median (IQR) days until patient transfer were 14 (10&#x02013;15), ranging from 1 to 28&#x02009;days after initial hospital admission. Amputations occurred in 11/14 patients transferred to a burn center compared to 70/104 patients not transferred to a burn center (<italic>p</italic>&#x02009;=&#x02009;0.385). Median (IQR) extent of amputations were 61 (56&#x02013;67) for patients transferred to a burn center compared to 56 (5.25&#x02013;84) for patients not transferred to a burn center (<italic>p</italic>&#x02009;=&#x02009;0.248). Median (IQR) hospital LOS was 78 (35&#x02013;140) days for patients transferred to a burn center compared to 57 (44&#x02013;85) days for patients not transferred to a burn center (<italic>p</italic>&#x02009;=&#x02009;0.585). Six complications occurred in 14 patients transferred to a burn center compared to 23 complications in 104 patients not transferred to a burn center (<italic>p</italic>&#x02009;=&#x02009;0.189). Mortality occurred in 3/14 patients transferred to a burn center compared to 11/104 patients not transferred to a burn center (<italic>p</italic>&#x02009;=&#x02009;0.385). These findings were not significant.</p></sec><sec id="Sec16"><title>Non-surgical interventions</title><p id="Par40">Protein C use was reported in 23/190 (12%)&#x000a0;cases, antithrombin use in 5/190 (3%)&#x000a0;cases, immunoglobulin use in 2/190 (1%)&#x000a0;cases, and plasmapheresis use in 3/190 (2%)&#x000a0;cases. Hyperbaric oxygen use was reported in 3/190 (2%)&#x000a0;cases. Negative pressure wound therapy use was reported in 9/190 (5%)&#x000a0;cases.</p></sec><sec id="Sec17"><title>Surgical interventions</title><p id="Par41">A total of 71/190 (38%)&#x000a0;cases reported surgical debridement. Median (IQR) time to debridement was 12.5 (1.8&#x02013;20.3) days, ranging from one to 42&#x02009;days. Fasciotomies were reported in 12/190 (6%)&#x000a0;cases and 20 procedures. Amputations were reported in 154/190 (81%)&#x000a0;cases. Median (IQR) time to amputation was 18 (14&#x02013;28) days, ranging from one to 56&#x02009;days. There were 64 BKAs, 30 AKAs, 28 below-the-elbow, and three above-the-elbow amputations. Reconstruction was reported in 45 cases. Median (IQR) time to reconstruction was 39 (23&#x02013;56) days, ranging from 13 to 224&#x02009;days. Skin grafts were applied in 33 cases. There were three ADMs, 13 split-thickness grafts, one full-thickness graft, five undifferentiated allografts, seven undifferentiated autografts cases, and four unknown grafts. Graft survival was reported in eight cases. Flaps were used for reconstruction in 28 cases. There were seven latissimus dorsi, two serratus anterior, four orbicularis oris, one posterolateral thigh, one free anterolateral thigh, one free medial gastrocnemius, one gracilis, one internal island saphenous, one free forearm, one lateral arm, and one forehead flap. Median (IQR) surgical procedures per patient were 4 (4, 5) procedures, ranging from two to eight procedures. Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref> compares the extent of amputations, associated with different organisms. Coagulase-negative <italic>Staphylococcus</italic> (95%CI (8.2&#x02013;177.9), <italic>p</italic>&#x02009;=&#x02009;0.032), <italic>Haemophilus influenza</italic> (95%CI (7.2&#x02013;133), <italic>p</italic>&#x02009;=&#x02009;0.029), <italic>Streptococcus pneumonia</italic> (95%CI (13.3&#x02013;75.9), <italic>p</italic>&#x02009;=&#x02009;0.006), and West Nile Virus (95%CI (8.2&#x02013;177.9), <italic>p</italic>&#x02009;=&#x02009;0.032) were associated with significantly more extensive amputations compared to other organisms. There were no significant differences for times to amputation after comparing patients infected with the different organisms.
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Comparisons between the numbers of the bones removed or transected from patients during amputation with a specific organism using linear regression from quantitative data synthesis</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Organisms</th><th>Number of the bones removed or transected, Median (IQR)</th><th>Unstandardized beta coefficient (bones removed or transected)</th><th>95%CI</th><th><italic>P</italic> value</th></tr></thead><tbody><tr><td>
<italic>Bacteroides fragilis</italic>
</td><td>28 (28&#x02013;28)</td><td>1.152</td><td>[&#x02212;&#x02009;83.7&#x02013;86]</td><td>0.978</td></tr><tr><td>
<italic>Capnocytophaga canimorsus</italic>
</td><td>54 (11&#x02013;63)</td><td>21.425</td><td>[&#x02212;&#x02009;16.5&#x02013;59.3]</td><td>0.264</td></tr><tr><td>
<italic>Capnocytophaga ochracea</italic>
</td><td>84 (84&#x02013;84)</td><td>60.980</td><td>[&#x02212;&#x02009;23.8&#x02013;145.8]</td><td>0.156</td></tr><tr><td>
<italic>Chlamydia pneumonia</italic>
</td><td>0 (0&#x02013;0)</td><td>&#x02212;&#x02009;28.762</td><td>[&#x02212;&#x02009;113.6&#x02013;56.1]</td><td>0.501</td></tr><tr><td>Coagulase-negative <italic>Staphylococcus</italic></td><td>114 (114&#x02013;114)</td><td>93.030</td><td>[8.2&#x02013;177.9]</td><td>
<italic>0.032</italic>
</td></tr><tr><td>Cytomegalovirus</td><td>0 (0&#x02013;0)</td><td>&#x02212;&#x02009;28.762</td><td>[&#x02212;&#x02009;113.6&#x02013;56.1]</td><td>0.501</td></tr><tr><td>
<italic>Escherichia coli</italic>
</td><td>56 (25&#x02013;56)</td><td>32.361</td><td>[&#x02212;&#x02009;12.5&#x02013;77.2]</td><td>0.115</td></tr><tr><td>
<italic>Gemella bergeri</italic>
</td><td>56 (56&#x02013;56)</td><td>31.066</td><td>[&#x02212;&#x02009;53.8&#x02013;115.9]</td><td>0.468</td></tr><tr><td>
<italic>Haemophilus influenza</italic>
</td><td>93 (79&#x02013;106)</td><td>70.088</td><td>[7.2&#x02013;133]</td><td>
<italic>0.029</italic>
</td></tr><tr><td>
<italic>Klebsiella pneumonia</italic>
</td><td>0 (0&#x02013;0)</td><td>&#x02212;&#x02009;12.728</td><td>[&#x02212;&#x02009;75.6&#x02013;50.2]</td><td>0.688</td></tr><tr><td>Leptospirosis</td><td>3 (3&#x02013;3)</td><td>&#x02212;&#x02009;25.557</td><td>[&#x02212;&#x02009;110.4&#x02013;59.3]</td><td>0.550</td></tr><tr><td>
<italic>Neisseria meningitidis</italic>
</td><td>56 (18&#x02013;61)</td><td>20.207</td><td>[&#x02212;&#x02009;10.4&#x02013;50.8]</td><td>0.192</td></tr><tr><td>No organism</td><td>60 (30&#x02013;87)</td><td>32.136</td><td>[&#x02212;&#x02009;16.2&#x02013;80.5]</td><td>0.190</td></tr><tr><td>
<italic>Pasteurella multocida</italic>
</td><td>59 (59&#x02013;59)</td><td>34.271</td><td>[&#x02212;&#x02009;50.6&#x02013;119.1]</td><td>0.423</td></tr><tr><td>
<italic>Plasmodium falciparum</italic>
</td><td>71 (50&#x02013;93)</td><td>47.104</td><td>[&#x02212;&#x02009;15.8&#x02013;110]</td><td>0.140</td></tr><tr><td>
<italic>Proteus mirabilis</italic>
</td><td>0 (0&#x02013;0)</td><td>&#x02212;&#x02009;28.762</td><td>[&#x02212;&#x02009;113.6&#x02013;56.1]</td><td>0.501</td></tr><tr><td>
<italic>Staphylococcus aureus</italic>
</td><td>75 (42&#x02013;99)</td><td>41.780</td><td>[&#x02212;&#x02009;6.6&#x02013;90.1]</td><td>0.089</td></tr><tr><td>
<italic>Streptococccus pneumonia</italic>
</td><td>85 (41&#x02013;95)</td><td>44.603</td><td>[13.3&#x02013;75.9]</td><td>
<italic>0.006</italic>
</td></tr><tr><td>
<italic>Streptococccus pyogenes</italic>
</td><td>90 (45&#x02013;105)</td><td>45.692</td><td>[&#x02212;&#x02009;7.9&#x02013;99.3]</td><td>0.094</td></tr><tr><td>
<italic>Trichosporon asahii</italic>
</td><td>0 (0&#x02013;0)</td><td>&#x02212;&#x02009;28.762</td><td>[&#x02212;&#x02009;113.6&#x02013;56.1]</td><td>0.501</td></tr><tr><td>Unknown</td><td>0 (0&#x02013;84)</td><td>14.600</td><td>[&#x02212;&#x02009;27.8&#x02013;57]</td><td>0.495</td></tr><tr><td>Varicella</td><td>14 (14&#x02013;14)</td><td>&#x02212;&#x02009;13.805</td><td>[&#x02212;&#x02009;98.6&#x02013;71]</td><td>0.747</td></tr><tr><td>West Nile Virus</td><td>114 (114&#x02013;114)</td><td>93.030</td><td>[8.2&#x02013;177.9]</td><td>
<italic>0.032</italic>
</td></tr></tbody></table><table-wrap-foot><p><italic>IQR</italic> interquartile range, <italic>CI</italic> confidence interval</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec18"><title>Hospital LOS</title><p id="Par42">Median (IQR) hospital LOS reported in 50/190 cases was 57 (43.3&#x02013;87.8) days, ranging from 11 to 292&#x02009;days. There were no significant differences in hospital LOS after comparing patients infected with the different organisms.</p></sec><sec id="Sec19"><title>Complications</title><p id="Par43">Complications occurred in 28/190 cases. Secondary infections were the most common complication in 20 cases, followed by DVT/PE in five cases, scarring in five cases, contracture in three cases, pressure ulcer in one case, wound breakdown in one case, alar stenosis in one case, facial deformity in one case, and heterotopic ossification in one case. There were no significant differences in complications after comparing patients infected with the different organisms.</p></sec><sec id="Sec20"><title>Mortality</title><p id="Par44">Mortality was reported in 34/190 (18%) cases. Median (IQR) time to mortality was 36 (26.3&#x02013;72.8) days, ranging from 3 to 84. Median (IQR) follow-up was 365 (365&#x02013;730) days, ranging from 28 to 2884&#x02009;days. There were no significant differences in mortality after comparing patients infected with the different organisms.</p></sec></sec><sec id="Sec21"><title>Discussion</title><p id="Par45">This was the first systematic review and meta-analysis that compared infectious etiologies, signs and symptoms, and surgical outcomes associated with cutaneous manifestations in adults with PF. Most patients presented with septic shock due to infectious etiology. Similar to children, the most common infectious etiologies were <italic>Neisseria meningitidis</italic> and <italic>Streptococccus pneumonia</italic> in adults. Early identification of these organisms may allow the transfer of these patients to a higher level of care sooner to optimize patient outcomes. Patients had a median involvement of four limbs, %TBSA ranged from 20% to 70%, and 7% of cases were managed in a burn center. Assessing the involvement of four limbs and greater than 20% of the skin could play an important role for diagnostic criteria. Burn center management provides multidisciplinary staff trained to utilize resources for burn and non-burn skin wounds to improve patient outcomes [<xref ref-type="bibr" rid="CR88">88</xref>]. The most common surgeries performed were amputations, with BKAs being the most common procedure. Skin grafting was the most commonly performed reconstructive procedure. Coagulase-negative <italic>Staphylococcus</italic>, <italic>Haemophilus influenza</italic>, <italic>Streptococccus pneumonia</italic>, and West Nile Virus were associated with more extensive amputations. Although coagulase-negative <italic>Staphylococcus</italic>, <italic>Haemophilus influenza</italic>, and West Nile Virus were associated with more extensive amputations, the small sample sizes for each organism were likely to over-estimate the effects of these results. The most common complications were secondary infections. Median hospital LOS was 57&#x02009;days, ranging from 11 to 292&#x02009;days. The rate of mortality was 18% from the 190 adult cases. Previous literature describes mortality ranging from 20% to 60%, with inclusion of data from pediatric populations [<xref ref-type="bibr" rid="CR2">2</xref>]. Lower mortality rates observed in our study may be due to publication bias. Case reports involving patient deaths may be less likely to result in publication and appear in the literature. This effect may artificially lower the reported mortality rates.</p><p id="Par46">Conservative surgical management should be considered for patients with PF. Surgical procedures interrupt anticoagulant administration and disrupt the skin barrier, resulting in susceptibility to secondary infections. During the early stages of PF, it is difficult to differentiate between viable and nonviable tissue. Extensive surgical management may result in unnecessary tissue loss. Avoiding early amputation in favor of autoamputation when applicable can minimize tissue loss and patient morbidity [<xref ref-type="bibr" rid="CR89">89</xref>]. Fasciotomy is recommended for limb threatening ischemia and compromised blood flow from tissue edema [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR90">90</xref>]. Reconstructive procedures may be delayed until the underlying cause and pathophysiological state of PF is controlled [<xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par47">Studies that include surgical management of PF are primarily retrospectively designed. They are poor quality with many limitations. The majority of studies consisted of case reports, limiting use of forest plots, funnel plots, heterogeneity tests, and risks of bias. Times to debridement, times to burn center transfer, amputations, and reconstruction vary from study to study with conflicting results. Study populations vary from rural settings to cities, around the world, managed on standard hospital floors, intensive care units, and burn units. Studies ranged from 1968 through 2019, a 51-year time period. Our search revealed major gaps in reported data within the literature. Many studies reported regions of the body amputated, making it difficult to determine the level of transection. Types of skin grafts were not specified in many studies, along with many donor and recipient sites. Few studies differentiated the depth, locations and %TBSA of necrosis and surgical debridement. Many studies did not identify how patients were diagnosed with PF or etiologies. Non-surgical interventions were we underpowered in our study, limiting the interpretation of protein C administration for PF. Burn center management was reported in 14 cases. Some patients were transferred to a burn center after 28&#x02009;days of hospital management, limiting the interpretation of benefits from early advanced management. Comparative groups of organisms in the meta-analysis were unequal sizes with varying reports of outcomes, complications, and follow-up. Non-parametric tests were implemented; however, the small sample sizes may have resulted in misinterpretation of non-significant findings. Significant findings should be interpreted carefully, not to over-estimate the effects of our findings.</p><p id="Par48">All of these limitations demonstrate the importance for performing this systematic review and meta-analysis. By conducting this never performed review, we identified existing and future areas of research that can contribute a wealth of knowledge to the literature for healthcare providers, the public, and patients. In addition, we compared all available published data for adult surgical management of PF.</p></sec><sec id="Sec22"><title>Conclusion</title><p id="Par49">The most common presentation of PF was septic shock from an infectious organism. Similar to the pediatric population, <italic>Neisseria meningitidis</italic> and <italic>Streptococccus pneumonia</italic> were equally the most common organisms associated with PF in adults. The majority of cases were not treated in a burn center; however, given the extensive skin and soft tissue involvement, a burn center may be better equipped to manage these complicated patients. Interpretation of findings should be cautioned due to limited sample data.</p></sec><sec sec-type="supplementary-material"><title>Additional files</title><sec id="Sec23"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41038_2019_168_MOESM1_ESM.docx"><label>Additional file 1</label><caption><p>: Search strategies (DOCX 19&#x000a0;kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41038_2019_168_MOESM2_ESM.docx"><label>Additional file 2</label><caption><p>: Table S1. Case reports with surgical outcomes of purpura fulminans (DOCX 165&#x000a0;kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41038_2019_168_MOESM3_ESM.docx"><label>Additional file 3</label><caption><p>: Table S2. Cohort studies with surgical outcomes of purpura fulminans (DOCX 50&#x000a0;kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41038_2019_168_MOESM4_ESM.docx"><label>Additional file 4</label><caption><p>: Table S3. Methodological quality and synthesis of case series and case reports system [<xref ref-type="bibr" rid="CR10">10</xref>] (DOCX 131&#x000a0;kb)</p></caption></media></supplementary-material>
</p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>%TBSA</term><def><p id="Par4">Percent of&#x000a0;total body surface area</p></def></def-item><def-item><term>ADM</term><def><p id="Par5">Acellular dermal matrix</p></def></def-item><def-item><term>AKA</term><def><p id="Par6">Above-the-knee&#x000a0;amputation</p></def></def-item><def-item><term>ALT</term><def><p id="Par7">Anterolateral thigh</p></def></def-item><def-item><term>BKA</term><def><p id="Par8">Below-the-knee&#x000a0;amputation</p></def></def-item><def-item><term>CI</term><def><p id="Par9">Confidence intervals</p></def></def-item><def-item><term>DIC</term><def><p id="Par10">Disseminated intravascular coagulation</p></def></def-item><def-item><term>DVT</term><def><p id="Par11">Deep vein thrombosis</p></def></def-item><def-item><term>FTSG</term><def><p id="Par12">Full-thickness skin graft</p></def></def-item><def-item><term>IQR</term><def><p id="Par13">Interquartile range</p></def></def-item><def-item><term>LOS</term><def><p id="Par14">Length of stay</p></def></def-item><def-item><term>OR</term><def><p id="Par15">Odds ratios</p></def></def-item><def-item><term>PE</term><def><p id="Par16">Pulmonary embolism</p></def></def-item><def-item><term>PF</term><def><p id="Par17">Purpura fulminans</p></def></def-item><def-item><term>PICOS</term><def><p id="Par18">Participants, interventions, comparisons, outcomes, and study design</p></def></def-item><def-item><term>PRISMA</term><def><p id="Par19">Preferred Reporting Items for Systematic Reviews and Meta-analysis</p></def></def-item><def-item><term>RCT</term><def><p id="Par20">Randomized controlled trial</p></def></def-item><def-item><term>STSG</term><def><p id="Par21">Split-thickness skin graft</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>We thank Carrie Cox, MS, RN, and Vidhi Javia, BS, for assistance with coordinating clinical research at The Johns Hopkins Burn Center. Without their assistance, our work would not be possible.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>The authors KMK, CFG, MJG, SMS, MA, CSH, and JAC all contributed equally to conception and design, acquisition of data, or analysis and interpretation of data. KMK drafted the manuscript. MA, CSH, and JAC revised it critically for important intellectual content. All authors KMK, CFG, MJG, SMS, MA, CSH, and JAC approved the final manuscript version to be published. All authors KMK, CFG, MJG, SMS, MA, CSH, and JAC agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The data used and/or analyzed during the current study are accessible online.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par50">Not applicable.</p></notes><notes><title>Consent for publication</title><p id="Par51">Not applicable</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par52">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>ME</given-names></name><name><surname>Maijub</surname><given-names>JG</given-names></name><name><surname>Walker</surname><given-names>SK</given-names></name><name><surname>Gardner</surname><given-names>GP</given-names></name><name><surname>Jones</surname><given-names>RG</given-names></name></person-group><article-title>Meningococcal sepsis and purpura fulminans: the surgical perspective</article-title><source>Postgrad Med J</source><year>2013</year><volume>89</volume><issue>1052</issue><fpage>340</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1136/postgradmedj-2012-130989</pub-id><pub-id pub-id-type="pmid">23389283</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colling</surname><given-names>ME</given-names></name><name><surname>Bendapudi</surname><given-names>PK</given-names></name></person-group><article-title>Purpura fulminans: mechanism and management of dysregulated hemostasis</article-title><source>Transfus Med Rev</source><year>2018</year><volume>32</volume><issue>2</issue><fpage>69</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.tmrv.2017.10.001</pub-id><pub-id pub-id-type="pmid">29157918</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betrosian</surname><given-names>AP</given-names></name><name><surname>Berlet</surname><given-names>T</given-names></name><name><surname>Agarwal</surname><given-names>B</given-names></name></person-group><article-title>Purpura fulminans in sepsis</article-title><source>Am J Med Sci</source><year>2006</year><volume>332</volume><issue>6</issue><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1097/00000441-200612000-00006</pub-id><pub-id pub-id-type="pmid">17170624</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guelliot</surname><given-names>A</given-names></name></person-group><article-title>Note sur trois cas de purpura infectieux foudroyant</article-title><source>Union med et scient du nord-est</source><year>1884</year><volume>8</volume><fpage>25</fpage><lpage>37</lpage></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adcock</surname><given-names>DM</given-names></name><name><surname>Brozna</surname><given-names>J</given-names></name><name><surname>Marlar</surname><given-names>RA</given-names></name></person-group><article-title>Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis</article-title><source>Semin Thromb Hemost</source><year>1990</year><volume>16</volume><issue>4</issue><fpage>333</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1055/s-2007-1002686</pub-id><pub-id pub-id-type="pmid">2281322</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pino</surname><given-names>PA</given-names></name><name><surname>Roman</surname><given-names>JA</given-names></name><name><surname>Fernandez</surname><given-names>F</given-names></name></person-group><source>Delayed surgical debridement and use of semiocclusive dressings for salvage of fingers after purpura fulminans</source><year>2016</year><publisher-loc>New York</publisher-loc><publisher-name>Hand</publisher-name><fpage>Np34-np37</fpage></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campsall</surname><given-names>PA</given-names></name><name><surname>Laupland</surname><given-names>KB</given-names></name><name><surname>Niven</surname><given-names>DJ</given-names></name></person-group><article-title>Severe meningococcal infection: a review of epidemiology, diagnosis, and management</article-title><source>Crit Care Clin</source><year>2013</year><volume>29</volume><issue>3</issue><fpage>393</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1016/j.ccc.2013.03.001</pub-id><pub-id pub-id-type="pmid">23830646</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roughton</surname><given-names>MC</given-names></name><name><surname>Agarwal</surname><given-names>S</given-names></name><name><surname>Gottlieb</surname><given-names>LJ</given-names></name></person-group><article-title>Surgical management of acute infectious purpura fulminans</article-title><source>J Burn Care Res</source><year>2011</year><volume>32</volume><issue>2</issue><fpage>231</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1097/BCR.0b013e31820aaef1</pub-id><pub-id pub-id-type="pmid">21233723</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Mulrow</surname><given-names>C</given-names></name><name><surname>Gotzsche</surname><given-names>PC</given-names></name><name><surname>Ioannidis</surname><given-names>JP</given-names></name><etal/></person-group><article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration</article-title><source>PLoS Med</source><year>2009</year><volume>6</volume><issue>7</issue><fpage>e1000100</fpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1000100</pub-id><pub-id pub-id-type="pmid">19621070</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murad</surname><given-names>MH</given-names></name><name><surname>Sultan</surname><given-names>S</given-names></name><name><surname>Haffar</surname><given-names>S</given-names></name><name><surname>Bazerbachi</surname><given-names>F</given-names></name></person-group><article-title>Methodological quality and synthesis of case series and case reports</article-title><source>BMJ Evid Based Med</source><year>2018</year><volume>23</volume><issue>2</issue><fpage>60</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1136/bmjebm-2017-110853</pub-id><pub-id pub-id-type="pmid">29420178</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>RD</given-names></name><name><surname>Lambert</surname><given-names>PC</given-names></name><name><surname>Abo-Zaid</surname><given-names>G</given-names></name></person-group><article-title>Meta-analysis of individual participant data: rationale, conduct, and reporting</article-title><source>BMJ</source><year>2010</year><volume>340</volume><fpage>c221</fpage><pub-id pub-id-type="doi">10.1136/bmj.c221</pub-id><pub-id pub-id-type="pmid">20139215</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname><given-names>MP</given-names></name><name><surname>Sharma</surname><given-names>V</given-names></name></person-group><article-title>Clinical images: purpura fulminans caused by meningococcemia</article-title><source>CMAJ</source><year>2010</year><volume>182</volume><issue>1</issue><fpage>E18</fpage><pub-id pub-id-type="doi">10.1503/cmaj.090103</pub-id><pub-id pub-id-type="pmid">19858241</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>Z</given-names></name><name><surname>Jordan</surname><given-names>R</given-names></name><name><surname>Das-Gupta</surname><given-names>R</given-names></name><name><surname>Srivastava</surname><given-names>S</given-names></name></person-group><article-title>Two cases of meningococcal purpura fulminans: the &#x02018;less is more&#x02019; approach</article-title><source>Int Wound J</source><year>2014</year><volume>11</volume><issue>6</issue><fpage>636</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1111/iwj.12020</pub-id><pub-id pub-id-type="pmid">23323934</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreasen</surname><given-names>TJ</given-names></name><name><surname>Green</surname><given-names>SD</given-names></name><name><surname>Childers</surname><given-names>BJ</given-names></name></person-group><article-title>Massive infectious soft-tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans</article-title><source>Plast Reconstr Surg</source><year>2001</year><volume>107</volume><issue>4</issue><fpage>1025</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1097/00006534-200104010-00019</pub-id><pub-id pub-id-type="pmid">11252099</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amara</surname><given-names>M</given-names></name><name><surname>Bonacorsi</surname><given-names>S</given-names></name><name><surname>Bedel</surname><given-names>J</given-names></name><name><surname>Mira</surname><given-names>JP</given-names></name><name><surname>Laurent</surname><given-names>V</given-names></name><name><surname>Socha</surname><given-names>K</given-names></name><etal/></person-group><article-title>Group a <italic>Escherichia coli</italic>-related purpura fulminans: an unusual manifestation due to an unusual strain?</article-title><source>J Clin Microbiol</source><year>2014</year><volume>52</volume><issue>12</issue><fpage>4404</fpage><lpage>4406</lpage><pub-id pub-id-type="doi">10.1128/JCM.01362-14</pub-id><pub-id pub-id-type="pmid">25232165</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arevalo</surname><given-names>JM</given-names></name><name><surname>Lorente</surname><given-names>JA</given-names></name><name><surname>Fonseca</surname><given-names>R</given-names></name></person-group><article-title>Surgical treatment of extensive skin necrosis secondary to purpura fulminans in a patient with meningococcal sepsis</article-title><source>Burns</source><year>1998</year><volume>24</volume><issue>3</issue><fpage>272</fpage><lpage>274</lpage><pub-id pub-id-type="doi">10.1016/S0305-4179(97)00120-4</pub-id><pub-id pub-id-type="pmid">9677033</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnaiz-Garcia</surname><given-names>M</given-names></name><name><surname>Arnaiz-Garcia</surname><given-names>A</given-names></name><name><surname>Gutierrez-Diez</surname><given-names>F</given-names></name><name><surname>Nistal</surname><given-names>JF</given-names></name><name><surname>Gonzalez-Santos</surname><given-names>J</given-names></name><name><surname>Pulitani</surname><given-names>I</given-names></name><etal/></person-group><article-title>Mutilating purpura fulminans in an adult with meningococcal sepsis</article-title><source>P R Health Sci J</source><year>2017</year><volume>36</volume><issue>3</issue><fpage>179</fpage><lpage>182</lpage><pub-id pub-id-type="pmid">28915308</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendapudi</surname><given-names>PK</given-names></name><name><surname>Robbins</surname><given-names>A</given-names></name><name><surname>LeBoeuf</surname><given-names>N</given-names></name><name><surname>Pozdnyakova</surname><given-names>O</given-names></name><name><surname>Bhatt</surname><given-names>A</given-names></name><name><surname>Duke</surname><given-names>F</given-names></name><etal/></person-group><article-title>Persistence of endothelial thrombomodulin in a patient with infectious purpura fulminans treated with protein C concentrate</article-title><source>Blood Adv</source><year>2018</year><volume>2</volume><issue>21</issue><fpage>2917</fpage><lpage>2921</lpage><pub-id pub-id-type="doi">10.1182/bloodadvances.2018024430</pub-id><pub-id pub-id-type="pmid">30396911</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatti</surname><given-names>UF</given-names></name><name><surname>Williams</surname><given-names>AM</given-names></name><name><surname>Raghavendran</surname><given-names>K</given-names></name><name><surname>Georgoff</surname><given-names>PE</given-names></name></person-group><article-title>Four-extremity amputation following disseminated intravascular coagulation and purpura fulminans</article-title><source>BMJ Case Rep</source><year>2019</year><volume>12</volume><issue>3</issue><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1136/bcr-2018-228028</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bischof</surname><given-names>JE</given-names></name><name><surname>Wirt</surname><given-names>JN</given-names></name><name><surname>Tsukayama</surname><given-names>D</given-names></name></person-group><article-title>Delayed treatment of a dog bite resulting in devastating capnocytophaga sepsis in an alcoholic patient with functional asplenia</article-title><source>Infect Dis Clin Pract</source><year>2014</year><volume>22</volume><issue>4</issue><fpage>e105</fpage><lpage>e106</lpage></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bollero</surname><given-names>D</given-names></name><name><surname>Stella</surname><given-names>M</given-names></name><name><surname>Gangemi</surname><given-names>EN</given-names></name><name><surname>Spaziante</surname><given-names>L</given-names></name><name><surname>Nuzzo</surname><given-names>J</given-names></name><name><surname>Sigaudo</surname><given-names>G</given-names></name><etal/></person-group><article-title>Purpura fulminans in meningococcal septicaemia in an adult: a case report</article-title><source>Ann Burns Fire Disasters</source><year>2010</year><volume>23</volume><issue>1</issue><fpage>43</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">21991197</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borges</surname><given-names>L</given-names></name><name><surname>Oliveira</surname><given-names>N</given-names></name><name><surname>Cassio</surname><given-names>I</given-names></name><name><surname>Costa</surname><given-names>H</given-names></name></person-group><article-title>Sepsis-induced purpura fulminans caused by Pasteurella multocida</article-title><source>BMJ Case Rep.</source><year>2014</year><volume>2014</volume><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chasan</surname><given-names>PE</given-names></name><name><surname>Hansbrough</surname><given-names>JF</given-names></name><name><surname>Cooper</surname><given-names>ML</given-names></name></person-group><article-title>Management of cutaneous manifestations of extensive purpura fulminans in a burn unit</article-title><source>J Burn Care Rehabil</source><year>1992</year><volume>13</volume><issue>4</issue><fpage>410</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1097/00004630-199207000-00005</pub-id><pub-id pub-id-type="pmid">1429811</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>DK</given-names></name><name><surname>Lee</surname><given-names>MW</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Moon</surname><given-names>KC</given-names></name><name><surname>Koh</surname><given-names>JK</given-names></name></person-group><article-title>Vibrio vulnificus septicemia presenting as purpura fulminans</article-title><source>J Dermatol</source><year>2005</year><volume>32</volume><issue>1</issue><fpage>48</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1111/j.1346-8138.2005.tb00714.x</pub-id><pub-id pub-id-type="pmid">15841662</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christiansen</surname><given-names>CB</given-names></name><name><surname>Berg</surname><given-names>RMG</given-names></name><name><surname>Plovsing</surname><given-names>RR</given-names></name><name><surname>Moller</surname><given-names>K</given-names></name></person-group><article-title>Two cases of infectious purpura fulminans and septic shock caused by Capnocytophaga canimorsus transmitted from dogs</article-title><source>Scand J Infect Dis</source><year>2012</year><volume>44</volume><issue>8</issue><fpage>635</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.3109/00365548.2012.672765</pub-id><pub-id pub-id-type="pmid">22497463</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>DZ</given-names></name><name><surname>Blaisdell</surname><given-names>FW</given-names></name></person-group><article-title>Purpura fulminans</article-title><source>Am J Surg</source><year>1982</year><volume>143</volume><issue>3</issue><fpage>356</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/0002-9610(82)90106-4</pub-id><pub-id pub-id-type="pmid">6461269</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cone</surname><given-names>LA</given-names></name><name><surname>Waterbor</surname><given-names>RB</given-names></name><name><surname>Sofonio</surname><given-names>MV</given-names></name></person-group><article-title>Purpura fulminans due to Streptococcus pneumoniae sepsis following gastric bypass</article-title><source>Obes Surg</source><year>2004</year><volume>14</volume><issue>5</issue><fpage>690</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1381/096089204323093507</pub-id><pub-id pub-id-type="pmid">15186640</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contou</surname><given-names>Damien</given-names></name><name><surname>Sonneville</surname><given-names>Romain</given-names></name><name><surname>Canoui-Poitrine</surname><given-names>Florence</given-names></name><name><surname>Colin</surname><given-names>Gwenha&#x000eb;l</given-names></name><name><surname>Coudroy</surname><given-names>R&#x000e9;mi</given-names></name><name><surname>P&#x000e8;ne</surname><given-names>Fr&#x000e9;d&#x000e9;ric</given-names></name><name><surname>Tadi&#x000e9;</surname><given-names>Jean-Marc</given-names></name><name><surname>Cour</surname><given-names>Martin</given-names></name><name><surname>B&#x000e9;duneau</surname><given-names>Ga&#x000eb;tan</given-names></name><name><surname>Marchalot</surname><given-names>Antoine</given-names></name><name><surname>Gu&#x000e9;rin</surname><given-names>Laurent</given-names></name><name><surname>Jochmans</surname><given-names>S&#x000e9;bastien</given-names></name><name><surname>Ehrmann</surname><given-names>Stephan</given-names></name><name><surname>Terzi</surname><given-names>Nicolas</given-names></name><name><surname>Pr&#x000e9;au</surname><given-names>S&#x000e9;bastien</given-names></name><name><surname>Barbier</surname><given-names>Fran&#x000e7;ois</given-names></name><name><surname>Schnell</surname><given-names>Guillaume</given-names></name><name><surname>Roux</surname><given-names>Damien</given-names></name><name><surname>Leroy</surname><given-names>Olivier</given-names></name><name><surname>Pichereau</surname><given-names>Claire</given-names></name><name><surname>G&#x000e9;lisse</surname><given-names>Elodie</given-names></name><name><surname>Zafrani</surname><given-names>Lara</given-names></name><name><surname>Layese</surname><given-names>Richard</given-names></name><name><surname>Brun-Buisson</surname><given-names>Christian</given-names></name><name><surname>Mekontso Dessap</surname><given-names>Armand</given-names></name><name><surname>de Prost</surname><given-names>Nicolas</given-names></name></person-group><article-title>Clinical spectrum and short-term outcome of adult patients with purpura fulminans: a French multicenter retrospective cohort study</article-title><source>Intensive Care Medicine</source><year>2018</year><volume>44</volume><issue>9</issue><fpage>1502</fpage><lpage>1511</lpage><pub-id pub-id-type="doi">10.1007/s00134-018-5341-3</pub-id><pub-id pub-id-type="pmid">30128591</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dautzenberg</surname><given-names>KHW</given-names></name><name><surname>Polderman</surname><given-names>FN</given-names></name><name><surname>van Suylen</surname><given-names>RJ</given-names></name><name><surname>Moviat</surname><given-names>MAM</given-names></name></person-group><article-title>Purpura fulminans mimicking toxic epidermal necrolysis - additional value of 16S rRNA sequencing and skin biopsy</article-title><source>Neth J Med</source><year>2017</year><volume>75</volume><issue>4</issue><fpage>165</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">28522775</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>MD</given-names></name><name><surname>Dy</surname><given-names>KM</given-names></name><name><surname>Nelson</surname><given-names>S</given-names></name></person-group><article-title>Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic</article-title><source>J Am Acad Dermatol</source><year>2007</year><volume>57</volume><issue>6</issue><fpage>944</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1016/j.jaad.2007.07.039</pub-id><pub-id pub-id-type="pmid">17719676</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Salvia</surname><given-names>A</given-names></name><name><surname>Lanzara</surname><given-names>G</given-names></name><name><surname>De Leo</surname><given-names>D</given-names></name></person-group><article-title>A devastating case of purpura fulminans in a young adult seven years after a splenectomy: a case report</article-title><source>Med Sci Law</source><year>2008</year><volume>48</volume><issue>1</issue><fpage>75</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1258/rsmmsl.48.1.75</pub-id><pub-id pub-id-type="pmid">18341162</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dedy</surname><given-names>NJ</given-names></name><name><surname>Coghill</surname><given-names>S</given-names></name><name><surname>Chandrashekar</surname><given-names>NKS</given-names></name><name><surname>Bindra</surname><given-names>RR</given-names></name></person-group><article-title>Capnocytophaga canimorsus sepsis following a minor dog bite to the finger: case report</article-title><source>J Hand Surg</source><year>2016</year><volume>41</volume><issue>1</issue><fpage>81</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.jhsa.2015.10.011</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>SS</given-names></name><name><surname>Harrison</surname><given-names>RA</given-names></name><name><surname>Murphy</surname><given-names>MD</given-names></name></person-group><article-title>Capnocytophaga ochracea causing severe sepsis and purpura fulminans in an immunocompetent patient</article-title><source>J Inf Secur</source><year>2007</year><volume>54</volume><issue>2</issue><fpage>e107</fpage><lpage>e109</lpage></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duteille</surname><given-names>F</given-names></name><name><surname>Thibault</surname><given-names>F</given-names></name><name><surname>Perrot</surname><given-names>P</given-names></name><name><surname>Renard</surname><given-names>B</given-names></name><name><surname>Pannier</surname><given-names>M</given-names></name></person-group><article-title>Salvaging limbs in cases of severe purpura fulminans: advantages of free flaps</article-title><source>Plast Reconstr Surg</source><year>2006</year><volume>118</volume><issue>3</issue><fpage>681</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1097/01.prs.0000233039.99945.01</pub-id><pub-id pub-id-type="pmid">16932177</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dykstra</surname><given-names>BL</given-names></name><name><surname>Ramar</surname><given-names>K</given-names></name></person-group><article-title>19-year-old woman with multiorgan failure and purpura</article-title><source>Mayo Clin Proc</source><year>2014</year><volume>89</volume><issue>12</issue><fpage>1718</fpage><lpage>1721</lpage><pub-id pub-id-type="doi">10.1016/j.mayocp.2014.04.035</pub-id><pub-id pub-id-type="pmid">25468517</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Agwany</surname><given-names>A</given-names></name></person-group><article-title>Sepsis associated postpartum purpura fulminans</article-title><source>Rev Vasc Med</source><year>2017</year><volume>9</volume><fpage>19</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.rvm.2017.04.005</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname><given-names>A</given-names></name><name><surname>Shiraishi</surname><given-names>A</given-names></name><name><surname>Aiboshi</surname><given-names>J</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Otomo</surname><given-names>Y</given-names></name></person-group><article-title>A case of purpura fulminans caused by Hemophilus influenzae complicated by reversible cardiomyopathy</article-title><source>J Intensive Care</source><year>2014</year><volume>2</volume><issue>1</issue><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/2052-0492-2-13</pub-id><pub-id pub-id-type="pmid">25520829</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">Eng PC, Bryant C, Jackson SH. A case of infectious purpura fulminans: an unusual organism and method of diagnosis. Eur J Case Rep Intern Med. 2014;1(1).</mixed-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonkoua</surname><given-names>LK</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Canty</surname><given-names>E</given-names></name><name><surname>Fairfull</surname><given-names>A</given-names></name><name><surname>Benich</surname><given-names>S</given-names></name><name><surname>Knab</surname><given-names>A</given-names></name><etal/></person-group><article-title>Purpura fulminans from reduced protein S following cytomegalovirus and varicella infection</article-title><source>Am J Hematol</source><year>2019</year><volume>94</volume><issue>4</issue><fpage>491</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1002/ajh.25386</pub-id><pub-id pub-id-type="pmid">30585353</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gast</surname><given-names>T</given-names></name><name><surname>Kowal-Vern</surname><given-names>A</given-names></name><name><surname>An</surname><given-names>G</given-names></name><name><surname>Hanumadass</surname><given-names>ML</given-names></name></person-group><article-title>Purpura fulminans in an adult patient with Haemophilus influenzae sepsis: case report and review of the literature</article-title><source>J Burn Care Res</source><year>2006</year><volume>27</volume><issue>1</issue><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1097/01.bcr.0000194269.95027.51</pub-id><pub-id pub-id-type="pmid">16566545</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaucher</surname><given-names>S</given-names></name><name><surname>Stephanazzi</surname><given-names>J</given-names></name><name><surname>Jarraya</surname><given-names>M</given-names></name></person-group><article-title>Human skin allografts as a useful adjunct in the treatment of purpura fulminans</article-title><source>J Wound Care</source><year>2010</year><volume>19</volume><issue>8</issue><fpage>355</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.12968/jowc.2010.19.8.77714</pub-id><pub-id pub-id-type="pmid">20852508</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Bandyopadhyay</surname><given-names>D</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name></person-group><article-title>Symmetrical peripheral gangrene: a prospective study of 14 consecutive cases in a tertiary-care hospital in eastern India</article-title><source>J Eur Acad Dermatol Venereol</source><year>2010</year><volume>24</volume><issue>2</issue><fpage>214</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1111/j.1468-3083.2009.03329.x</pub-id><pub-id pub-id-type="pmid">19522719</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hage-Sleiman</surname><given-names>M</given-names></name><name><surname>Derre</surname><given-names>N</given-names></name><name><surname>Verdet</surname><given-names>C</given-names></name><name><surname>Pialoux</surname><given-names>G</given-names></name><name><surname>Gaudin</surname><given-names>O</given-names></name><name><surname>Senet</surname><given-names>P</given-names></name><etal/></person-group><article-title>Meningococcal purpura fulminans and severe myocarditis with clinical meningitis but no meningeal inflammation: a case report</article-title><source>BMC Infect Dis</source><year>2019</year><volume>19</volume><issue>1</issue><fpage>252</fpage><pub-id pub-id-type="doi">10.1186/s12879-019-3866-x</pub-id><pub-id pub-id-type="pmid">30871501</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagiya</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Miyamoto</surname><given-names>T</given-names></name><name><surname>Otsuka</surname><given-names>F</given-names></name></person-group><article-title>Systemic varicella-zoster virus infection in two critically ill patients in an intensive care unit</article-title><source>Virol J</source><year>2013</year><volume>10</volume><fpage>225</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-10-225</pub-id><pub-id pub-id-type="pmid">23829348</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Har-El</surname><given-names>G</given-names></name><name><surname>Nash</surname><given-names>M</given-names></name><name><surname>Chin</surname><given-names>NW</given-names></name><name><surname>Meltzer</surname><given-names>CJ</given-names></name><name><surname>Weiss</surname><given-names>MH</given-names></name></person-group><article-title>Purpura fulminans of the head and neck</article-title><source>Otolaryngol Head Neck Surg</source><year>1990</year><volume>103</volume><issue>4</issue><fpage>660</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1177/019459989010300425</pub-id><pub-id pub-id-type="pmid">2123330</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>Z</given-names></name><name><surname>Mullins</surname><given-names>RF</given-names></name><name><surname>Friedman</surname><given-names>BC</given-names></name><name><surname>Shaver</surname><given-names>JR</given-names></name><name><surname>Alam</surname><given-names>B</given-names></name><name><surname>Mian</surname><given-names>MA</given-names></name></person-group><article-title>Purpura fulminans: a case series managed at a regional burn center</article-title><source>J Burn Care Res</source><year>2008</year><volume>29</volume><issue>2</issue><fpage>411</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1097/BCR.0b013e3181667936</pub-id><pub-id pub-id-type="pmid">18354305</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hautekeete</surname><given-names>ML</given-names></name><name><surname>Berneman</surname><given-names>ZN</given-names></name><name><surname>Bieger</surname><given-names>R</given-names></name><name><surname>Stevens</surname><given-names>WJ</given-names></name><name><surname>Bridts</surname><given-names>C</given-names></name><name><surname>Buyssens</surname><given-names>N</given-names></name><etal/></person-group><article-title>Purpura fulminans in pneumococcal sepsis</article-title><source>Arch Intern Med</source><year>1986</year><volume>146</volume><issue>3</issue><fpage>497</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1001/archinte.1986.00360150107012</pub-id><pub-id pub-id-type="pmid">3754111</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herzog</surname><given-names>JL</given-names></name><name><surname>Morgan</surname><given-names>KP</given-names></name><name><surname>Paden</surname><given-names>MH</given-names></name><name><surname>Stone</surname><given-names>PA</given-names></name></person-group><article-title>Disseminated intravascular coagulation, meningococcal infection, and ischemic changes affecting the lower extremities: a case study</article-title><source>J Foot Ankle Surg</source><year>2010</year><volume>49</volume><issue>5</issue><fpage>489.e5</fpage><lpage>489.e9</lpage><pub-id pub-id-type="doi">10.1053/j.jfas.2010.04.005</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogarth</surname><given-names>DB</given-names></name><name><surname>Cheon</surname><given-names>PM</given-names></name><name><surname>Kassam</surname><given-names>J</given-names></name><name><surname>Seal</surname><given-names>AE</given-names></name><name><surname>Kavanagh</surname><given-names>AG</given-names></name></person-group><article-title>Penile necrosis secondary to purpura fulminans: a case report and review of literature</article-title><source>J Surg Case Rep</source><year>2017</year><volume>2017</volume><issue>5</issue><fpage>rjx078</fpage><pub-id pub-id-type="doi">10.1093/jscr/rjx078</pub-id><pub-id pub-id-type="pmid">28479975</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huemer</surname><given-names>GM</given-names></name><name><surname>Bonatti</surname><given-names>H</given-names></name><name><surname>Dunst</surname><given-names>KM</given-names></name></person-group><article-title>Purpura fulminans due to <italic>E. coli</italic> septicemia</article-title><source>Wien Klin Wochenschr</source><year>2004</year><volume>116</volume><issue>3</issue><fpage>82</fpage><pub-id pub-id-type="doi">10.1007/BF03040700</pub-id><pub-id pub-id-type="pmid">15008315</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichimiya</surname><given-names>M</given-names></name><name><surname>Takita</surname><given-names>Y</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Muto</surname><given-names>M</given-names></name></person-group><article-title>Case of purpura fulminans due to septicemia after artificial abortion</article-title><source>J Dermatol</source><year>2007</year><volume>34</volume><issue>11</issue><fpage>786</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1111/j.1346-8138.2007.00385.x</pub-id><pub-id pub-id-type="pmid">17973822</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>RT</given-names></name><name><surname>Luplow</surname><given-names>IRE</given-names></name></person-group><article-title>Adult purpura fulminans and digital necrosis associated with sepsis and the factor V mutation 7</article-title><source>J Am Med Assoc</source><year>1998</year><volume>280</volume><issue>21</issue><fpage>1829</fpage><lpage>1830</lpage><pub-id pub-id-type="doi">10.1001/jama.280.21.1829</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakob</surname><given-names>A</given-names></name><name><surname>Alexandrakis</surname><given-names>E</given-names></name><name><surname>Rompel</surname><given-names>R</given-names></name></person-group><article-title>Purpura fulminans secondary to respiratory infection</article-title><source>J Dtsch Dermatol Ges</source><year>2009</year><volume>7</volume><issue>2</issue><fpage>135</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">19371235</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jha</surname><given-names>P</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name></person-group><article-title>A case of acute purpura fulminans caused by streptococcus pneumoniae</article-title><source>Consultant</source><year>2016</year><volume>56</volume><issue>11</issue><fpage>1010</fpage><lpage>1012</lpage></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>RG</given-names></name><name><surname>Gardner</surname><given-names>GP</given-names></name><name><surname>Morris</surname><given-names>ME</given-names></name></person-group><article-title>Catheter-directed thrombolysis in a patient with purpura fulminans</article-title><source>Am Surg</source><year>2012</year><volume>78</volume><issue>11</issue><fpage>E448</fpage><lpage>E449</lpage><pub-id pub-id-type="pmid">23089413</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>SA</given-names></name><name><surname>Beers</surname><given-names>RJ</given-names></name><name><surname>Lentz</surname><given-names>CW</given-names></name></person-group><article-title>Use of acellular dermal replacement in reconstruction of nonhealing lower extremity wounds</article-title><source>J Burn Care Res</source><year>2011</year><volume>32</volume><issue>1</issue><fpage>124</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1097/BCR.0b013e318204b327</pub-id><pub-id pub-id-type="pmid">21131847</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Ohnishi</surname><given-names>K</given-names></name><name><surname>Sawada</surname><given-names>Y</given-names></name><name><surname>Suenaga</surname><given-names>M</given-names></name></person-group><article-title>Purpura fulminans: an unusual manifestation of severe falciparum malaria</article-title><source>Trans R Soc Trop Med Hyg</source><year>2007</year><volume>101</volume><issue>10</issue><fpage>1045</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1016/j.trstmh.2007.04.015</pub-id><pub-id pub-id-type="pmid">17588627</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YJ</given-names></name><name><surname>Kim</surname><given-names>SI</given-names></name><name><surname>Kim</surname><given-names>YR</given-names></name><name><surname>Park</surname><given-names>YM</given-names></name><name><surname>Park</surname><given-names>YJ</given-names></name><name><surname>Kang</surname><given-names>MW</given-names></name></person-group><article-title>Successful treatment of septic shock with purpura fulminans caused by Trichosporon asahii in an immunocompetent patient</article-title><source>Ann Clin Lab Sci</source><year>2007</year><volume>37</volume><issue>4</issue><fpage>366</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">18000295</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komatsu</surname><given-names>M</given-names></name><name><surname>Ishihara</surname><given-names>T</given-names></name><name><surname>Manabe</surname><given-names>S</given-names></name><name><surname>Kuwano</surname><given-names>K</given-names></name><name><surname>Oki</surname><given-names>M</given-names></name><name><surname>Yanagi</surname><given-names>H</given-names></name><etal/></person-group><article-title>A case of overwhelming postsplenectomy infection caused by Streptococcus pneumoniae with fulminant purpura</article-title><source>Tokai J Exp Clin Med</source><year>2017</year><volume>42</volume><issue>3</issue><fpage>130</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">28871581</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopinski</surname><given-names>JE</given-names></name><name><surname>De Jesus</surname><given-names>RA</given-names></name><name><surname>Boucher</surname><given-names>HR</given-names></name></person-group><article-title>Bilateral total knee arthroplasty with extensor mechanism allografts and flap reconstructions after soft-tissue joint destruction from purpura fulminans: a case report</article-title><source>JBJS Case Connect</source><year>2014</year><volume>4</volume><issue>2</issue><fpage>e43</fpage><lpage>ee4</lpage><pub-id pub-id-type="doi">10.2106/JBJS.CC.M.00243</pub-id><pub-id pub-id-type="pmid">29252347</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuwahara</surname><given-names>M</given-names></name><name><surname>Yurugi</surname><given-names>S</given-names></name><name><surname>Yamanaka</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>C</given-names></name><name><surname>Nakanishi</surname><given-names>T</given-names></name></person-group><article-title>Reconstruction of near-total loss of the upper and lower lips due to purpura fulminans with local tissue and a dual-skin paddled anterolateral thigh flap</article-title><source>Plast Reconstr Surg Glob Open</source><year>2017</year><volume>5</volume><issue>9</issue><fpage>e1505</fpage><pub-id pub-id-type="doi">10.1097/GOX.0000000000001505</pub-id><pub-id pub-id-type="pmid">29062669</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lerolle</surname><given-names>N</given-names></name><name><surname>Carlotti</surname><given-names>A</given-names></name><name><surname>Melican</surname><given-names>K</given-names></name><name><surname>Aubey</surname><given-names>F</given-names></name><name><surname>Pierrot</surname><given-names>M</given-names></name><name><surname>Diehl</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Assessment of the interplay between blood and skin vascular abnormalities in adult purpura fulminans</article-title><source>Am J Respir Crit Care Med</source><year>2013</year><volume>188</volume><issue>6</issue><fpage>684</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1164/rccm.201302-0228OC</pub-id><pub-id pub-id-type="pmid">23924269</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>P</given-names></name><name><surname>Nambi</surname><given-names>R</given-names></name><name><surname>Faruqi</surname><given-names>F</given-names></name></person-group><article-title>Atypical presentation of purpura fulminans following sepsis in an adult</article-title><source>BMJ Case Rep.</source><year>2011</year><volume>2011</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1136/bcr.03.2011.3996</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLennan</surname><given-names>SE</given-names></name><name><surname>Kitzmiller</surname><given-names>WJ</given-names></name><name><surname>Yakuboff</surname><given-names>KP</given-names></name></person-group><article-title>Free-tissue transfer for limb salvage in purpura fulminans</article-title><source>Plast Reconstr Surg</source><year>2001</year><volume>107</volume><issue>6</issue><fpage>1437</fpage><lpage>1442</lpage><pub-id pub-id-type="doi">10.1097/00006534-200105000-00019</pub-id><pub-id pub-id-type="pmid">11335814</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>MD</given-names></name><name><surname>Kao</surname><given-names>LW</given-names></name><name><surname>Sloan</surname><given-names>BK</given-names></name></person-group><article-title>Primary meningococcal arthritis leading to Neisseria meningitidies purpura fulminans</article-title><source>West J Emerg Med</source><year>2013</year><volume>14</volume><issue>2</issue><fpage>165</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.5811/westjem.2012.10.12906</pub-id><pub-id pub-id-type="pmid">23599862</pub-id></element-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moritz</surname><given-names>G</given-names></name><name><surname>Jenkins</surname><given-names>M</given-names></name><name><surname>Shetty</surname><given-names>D</given-names></name><name><surname>Blundell</surname><given-names>J</given-names></name></person-group><article-title>The case of the mysterious vanishing spleen: autosplenectomy complicating pneumococcal sepsis</article-title><source>BMJ Case Rep.</source><year>2017</year><volume>2017</volume><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nolan</surname><given-names>J</given-names></name><name><surname>Sinclair</surname><given-names>R</given-names></name></person-group><article-title>Review of management of purpura fulminans and two case reports</article-title><source>Br J Anaesth</source><year>2001</year><volume>86</volume><issue>4</issue><fpage>581</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1093/bja/86.4.581</pub-id><pub-id pub-id-type="pmid">11573639</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Note</surname><given-names>S</given-names></name><name><surname>Soentjens</surname><given-names>P</given-names></name><name><surname>Van Laer</surname><given-names>M</given-names></name><name><surname>Meert</surname><given-names>P</given-names></name><name><surname>Vanbrabant</surname><given-names>P</given-names></name></person-group><article-title>Streptococcal toxic shock syndrome in a returning traveller</article-title><source>Acta Clin Belg.</source><year>2018</year><volume>2018</volume><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1080/17843286.2018.1539634</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamura</surname><given-names>I</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Katsurada</surname><given-names>Y</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>F</given-names></name></person-group><article-title>Successful corticosteroid treatment for purpura fulminans associated with quinolone</article-title><source>Intern Med</source><year>2016</year><volume>55</volume><issue>20</issue><fpage>3047</fpage><lpage>3051</lpage><pub-id pub-id-type="doi">10.2169/internalmedicine.55.7170</pub-id><pub-id pub-id-type="pmid">27746448</pub-id></element-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozmen</surname><given-names>V</given-names></name><name><surname>Asoglu</surname><given-names>O</given-names></name><name><surname>Karanlik</surname><given-names>H</given-names></name><name><surname>Unal</surname><given-names>ES</given-names></name><name><surname>Yavuz</surname><given-names>E</given-names></name><name><surname>Kecer</surname><given-names>M</given-names></name></person-group><article-title>Disseminated necrosis of the breast associated with purpura fulminans</article-title><source>Breast J</source><year>2005</year><volume>11</volume><issue>3</issue><fpage>221</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1111/j.1075-122X.2005.21597.x</pub-id><pub-id pub-id-type="pmid">15871715</pub-id></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollard</surname><given-names>RL</given-names></name><name><surname>Kennedy</surname><given-names>PJ</given-names></name><name><surname>Maitz</surname><given-names>PK</given-names></name></person-group><article-title>The use of artificial dermis (Integra) and topical negative pressure to achieve limb salvage following soft-tissue loss caused by meningococcal septicaemia</article-title><source>J Plast Reconstr Aesthet Surg</source><year>2008</year><volume>61</volume><issue>3</issue><fpage>319</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/j.bjps.2007.10.029</pub-id><pub-id pub-id-type="pmid">18078796</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redett</surname><given-names>RJ</given-names></name><name><surname>Bury</surname><given-names>TF</given-names></name><name><surname>McClinton</surname><given-names>MA</given-names></name></person-group><article-title>The use of simultaneous free latissimus dorsi tissue transfers for reconstruction of bilateral upper extremities in a case of purpura fulminans</article-title><source>J Hand Surg</source><year>2000</year><volume>25</volume><issue>3</issue><fpage>559</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1053/jhsu.2000.6926</pub-id></element-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rintala</surname><given-names>E</given-names></name><name><surname>Kauppila</surname><given-names>M</given-names></name><name><surname>Seppala</surname><given-names>OP</given-names></name><name><surname>Voipio-Pulkki</surname><given-names>L</given-names></name><name><surname>Pettila</surname><given-names>V</given-names></name><name><surname>Rasi</surname><given-names>V</given-names></name><etal/></person-group><article-title>Protein C substitution in sepsis-associated purpura fulminans</article-title><source>Crit Care Med</source><year>2000</year><volume>28</volume><issue>7</issue><fpage>2373</fpage><lpage>2378</lpage><pub-id pub-id-type="doi">10.1097/00003246-200007000-00032</pub-id><pub-id pub-id-type="pmid">10921567</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saraceni</surname><given-names>C</given-names></name><name><surname>Schwed-Lustgarten</surname><given-names>D</given-names></name></person-group><article-title>Pneumococcal sepsis-induced purpura fulminans in an asplenic adult patient without disseminated intravascular coagulation</article-title><source>Am J Med Sci</source><year>2013</year><volume>346</volume><issue>6</issue><fpage>514</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1097/MAJ.0b013e31829e02d3</pub-id><pub-id pub-id-type="pmid">24185261</pub-id></element-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Fite</surname><given-names>LP</given-names></name><name><surname>Lane</surname><given-names>N</given-names></name><name><surname>Parekh</surname><given-names>P</given-names></name></person-group><article-title>Purpura fulminans associated with acute West Nile virus encephalitis</article-title><source>J Clin Virol</source><year>2016</year><volume>75</volume><fpage>1</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2015.11.034</pub-id><pub-id pub-id-type="pmid">26686320</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>LT</given-names></name><name><surname>Huang</surname><given-names>ME</given-names></name></person-group><article-title>Inpatient rehabilitation of survivors of purpura fulminans with multiple limb amputations: a case series</article-title><source>Arch Phys Med Rehabil</source><year>2009</year><volume>90</volume><issue>4</issue><fpage>696</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2008.09.573</pub-id><pub-id pub-id-type="pmid">19345788</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>RM</given-names></name><name><surname>Gorosh</surname><given-names>JE</given-names></name></person-group><article-title>Purpura fulminans</article-title><source>J Hand Surg</source><year>1990</year><volume>15</volume><issue>1</issue><fpage>172</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/S0363-5023(09)91127-3</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>OP</given-names></name><name><surname>White</surname><given-names>B</given-names></name><name><surname>Vaughan</surname><given-names>D</given-names></name><name><surname>Rafferty</surname><given-names>M</given-names></name><name><surname>Claffey</surname><given-names>L</given-names></name><name><surname>Lyons</surname><given-names>B</given-names></name><etal/></person-group><article-title>Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans</article-title><source>Lancet (London, England)</source><year>1997</year><volume>350</volume><issue>9091</issue><fpage>1590</fpage><lpage>1593</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(97)06356-3</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>B</given-names></name><name><surname>Sloane</surname><given-names>J</given-names></name><name><surname>Walsh</surname><given-names>S</given-names></name></person-group><article-title>Loss of orofacial tissue secondary to septic shock caused by Streptococcus pneumoniae</article-title><source>Br J Oral Maxillofac Surg</source><year>2016</year><volume>54</volume><issue>9</issue><fpage>1033</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1016/j.bjoms.2016.02.037</pub-id><pub-id pub-id-type="pmid">27006285</pub-id></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talwar</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Gopal</surname><given-names>MG</given-names></name><name><surname>Nandini</surname><given-names>AS</given-names></name></person-group><article-title>Spectrum of purpura fulminans: report of three classical prototypes and review of management strategies</article-title><source>Indian J Dermatol Venereol Leprol</source><year>2012</year><volume>78</volume><issue>2</issue><fpage>228</fpage><pub-id pub-id-type="doi">10.4103/0378-6323.93655</pub-id><pub-id pub-id-type="pmid">22421668</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanosaki</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>N</given-names></name><name><surname>Lian</surname><given-names>CG</given-names></name><name><surname>Jurchak</surname><given-names>M</given-names></name><name><surname>Patel</surname><given-names>V</given-names></name></person-group><article-title>Purpura fulminans managed with multi-limb amputation: substituted judgment and surrogate decision-making in the surgical management of necrotizing soft tissue infections</article-title><source>Surg Infect</source><year>2014</year><volume>15</volume><issue>6</issue><fpage>853</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1089/sur.2013.223</pub-id></element-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urushidate</surname><given-names>S</given-names></name><name><surname>Yokoi</surname><given-names>K</given-names></name><name><surname>Higuma</surname><given-names>Y</given-names></name><name><surname>Mikami</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><etal/></person-group><article-title>Nose and upper lip reconstruction for purpura fulminans</article-title><source>J Plast Reconstr Aesthet Surg</source><year>2012</year><volume>65</volume><issue>2</issue><fpage>252</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1016/j.bjps.2011.07.004</pub-id><pub-id pub-id-type="pmid">21795130</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Horst</surname><given-names>RL</given-names></name></person-group><article-title>Purpura fulminans--a brief report of three cases</article-title><source>S Afr Med J</source><year>1968</year><volume>42</volume><issue>47</issue><fpage>1293</fpage><lpage>1295</lpage><pub-id pub-id-type="pmid">5719976</pub-id></element-citation></ref><ref id="CR84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamagishi</surname><given-names>T</given-names></name><name><surname>Hikone</surname><given-names>M</given-names></name><name><surname>Sugiyama</surname><given-names>K</given-names></name><name><surname>Tanabe</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>Y</given-names></name><name><surname>Furugaito</surname><given-names>M</given-names></name><etal/></person-group><article-title>Purpura fulminans with Lemierre&#x02019;s syndrome caused by Gemella bergeri and <italic>Eikenella corrodens</italic>: a case report</article-title><source>BMC Infect Dis</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>523</fpage><pub-id pub-id-type="doi">10.1186/s12879-018-3437-6</pub-id><pub-id pub-id-type="pmid">30340466</pub-id></element-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>VD</given-names></name><name><surname>Van Vliet</surname><given-names>ACM</given-names></name><name><surname>Maraha</surname><given-names>B</given-names></name><name><surname>Ponssen</surname><given-names>HH</given-names></name></person-group><article-title>Fibrinolytic therapy in Capnocytophaga canimorsus sepsis after dog bite 2</article-title><source>Intensive Care Med</source><year>2004</year><volume>30</volume><issue>10</issue><fpage>1980</fpage><pub-id pub-id-type="doi">10.1007/s00134-004-2387-1</pub-id><pub-id pub-id-type="pmid">15232682</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimoto</surname><given-names>K</given-names></name><name><surname>Okuma</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Mita</surname><given-names>T</given-names></name><name><surname>Mitsumoto</surname><given-names>A</given-names></name><name><surname>Yamasaki</surname><given-names>N</given-names></name><etal/></person-group><article-title>Limb fitting for quadruple amputees: report of two cases of symmetrical peripheral gangrene caused by pneumococcal purpura fulminans</article-title><source>Prosthetics Orthot Int</source><year>2013</year><volume>37</volume><issue>6</issue><fpage>489</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1177/0309364613481797</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerbib</surname><given-names>P</given-names></name><name><surname>Patenotre</surname><given-names>P</given-names></name><name><surname>Chambon</surname><given-names>JP</given-names></name></person-group><article-title>Purpura fulminans in an asplenic patient</article-title><source>Br J Haematol</source><year>2007</year><volume>139</volume><issue>2</issue><fpage>171</fpage><pub-id pub-id-type="doi">10.1111/j.1365-2141.2007.06770.x</pub-id><pub-id pub-id-type="pmid">17897291</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papp</surname><given-names>A</given-names></name><name><surname>Sikora</surname><given-names>S</given-names></name><name><surname>Evans</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>D</given-names></name><name><surname>Kirchhof</surname><given-names>M</given-names></name><name><surname>Miliszewski</surname><given-names>M</given-names></name><etal/></person-group><article-title>Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results</article-title><source>Burns</source><year>2018</year><volume>44</volume><issue>4</issue><fpage>807</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1016/j.burns.2017.10.022</pub-id><pub-id pub-id-type="pmid">29627131</pub-id></element-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warkentin</surname><given-names>TE</given-names></name></person-group><article-title>Ischemic limb gangrene with pulses</article-title><source>N Engl J Med</source><year>2015</year><volume>373</volume><issue>7</issue><fpage>642</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1056/NEJMra1316259</pub-id><pub-id pub-id-type="pmid">26267624</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>PM</given-names></name><name><surname>Kagan</surname><given-names>RJ</given-names></name><name><surname>Yakuboff</surname><given-names>KP</given-names></name><name><surname>Kemalyan</surname><given-names>N</given-names></name><name><surname>Palmieri</surname><given-names>TL</given-names></name><name><surname>Greenhalgh</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Current management of purpura fulminans: a multicenter study</article-title><source>J Burn Care Rehabil</source><year>2003</year><volume>24</volume><issue>3</issue><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1097/01.BCR.0000066789.79129.C2</pub-id><pub-id pub-id-type="pmid">12792230</pub-id></element-citation></ref></ref-list></back></article>